GSK-111426

Study Sponsor: GSK

Study Title

Case-control Study to Evaluate the Vaccine Effectiveness of GlaxoSmithKline (GSK) Biologicals' Live Attenuated Human Rotavirus (HRV) Vaccine (Rotarix™) Against Community-acquired Rotavirus Severe Gastroenteritis (RV SGE) Among Hospitalised Children Born After 1 October 2006, in Belgium

Medicine or Vaccine (generic name)

Rotavirus Vaccine

Sponsor Identification Number

111426

Trial Registry Identification Number(#'s)

NCT01177826

Medical Condition

Infections, Rotavirus

Phase

Phase 4

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=111426

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT01177826

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

An annotated case report form is not available for this study. A blank case report form will be provided.

Date Added to this Site

May 2016